|259.83||-0.6000||-0.23%||Vol 254.48K||1Y Perf 49.67%|
|Jun 16th, 2021 12:49 DELAYED|
|- -%||- -|
|Target Price||282.08||Analyst Rating||Strong Buy 1.32|
|Potential %||8.58||Finscreener Ranking||★★★★+ 56.83|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★+ 59.23|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 63.66|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||25.39B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||83.32||Earnings Date||27th Jul 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||27th Jul 2021|
|Estimated EPS Next Report||5.66|
|EPS Growth Next 5 Years %||10.60|
|Avg. Weekly Volume||565.80K|
|Avg. Monthly Volume||733.72K|
|Avg. Quarterly Volume||645.05K|
Laboratory Corporation of America Holdings (NYSE: LH) stock closed at 260.43 per share at the end of the most recent trading day (a 0.23% change compared to the prior day closing price) with a volume of 519.79K shares and market capitalization of 25.39B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 72400 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.
The one-year performance of Laboratory Corporation of America Holdings stock is 49.67%, while year-to-date (YTD) performance is 27.94%. LH stock has a five-year performance of 104.5%. Its 52-week range is between 155.65 and 280.69, which gives LH stock a 52-week price range ratio of 83.32%
Laboratory Corporation of America Holdings currently has a PE ratio of 9.60, a price-to-book (PB) ratio of 2.52, a price-to-sale (PS) ratio of 1.66, a price to cashflow ratio of 8.20, a PEG ratio of 2.32, a ROA of 13.62%, a ROC of 18.31% and a ROE of 30.22%. The company’s profit margin is 17.42%, its EBITDA margin is 28.60%, and its revenue ttm is $15.32 Billion , which makes it $156.77 revenue per share.
Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $5.66 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 27th Jul 2021.
The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.32), with a target price of $282.08, which is +8.58% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Laboratory Corporation of America Holdings has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Laboratory Corporation of America Holdings has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.00, ATR14 : 4.77, CCI20 : -85.39, Chaikin Money Flow : -0.21, MACD : -1.76, Money Flow Index : 26.65, ROC : -5.44, RSI : 41.41, STOCH (14,3) : 15.75, STOCH RSI : 0.69, UO : 39.02, Williams %R : -84.25), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Amy B. Summy (Option Excercise at a value of $0), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $0), Jean-Luc Belingard (Option Excercise at a value of $256 074), Jean-Luc Belingard (Sold 2 600 shares of value $699 803 ), Jeffrey A. Davis (Option Excercise at a value of $0), Judith C. Seltz (Option Excercise at a value of $0), Kerrii B. Anderson (Option Excercise at a value of $0), Lance V. Berberian (Option Excercise at a value of $0), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 1 646 shares of value $384 598 ), Paul Kirchgraber (Option Excercise at a value of $0), Paul Kirchgraber (Sold 4 000 shares of value $1 012 579 ), Peter J. Wilkinson (Option Excercise at a value of $340 251), Peter J. Wilkinson (Sold 2 317 shares of value $559 589 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert Sanders Williams (Option Excercise at a value of $384 111), Robert Sanders Williams (Sold 2 600 shares of value $450 112 ), Sandra D. van der Vaart (Option Excercise at a value of $381 870), Sandra D. van der Vaart (Sold 7 371 shares of value $1 765 574 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.